Patent · US Active

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

US7759366B2 · kind B2 · utility

3Cited by

1References

19Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Gerhard Jaehne · Frankfurt, DE
Siegfried Stengelin · Frankfurt am Main, DE
Matthias Gossel · Frankfurt am Main, DE
Thomas Klabunde · Frankfurt, DE
Irvin Winkler · Liederbach, DE

Key dates

Filing date	Feb 5, 2009
Grant date	Jul 20, 2010
Priority date	—
Expiry date	Feb 5, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts:Wherein R, R′, R1 to R10, A, D, E, G, L and p are as defined herein. The invention also relates to processes for preparing them, pharmaceutical compositions comprising them and their therapeutic use. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.